Rotavirus Vaccine Completed Phase 3 Trials for Infections, Rotavirus / Meningococcal Meningitis Prevention

CompletedPrevention3 IdentifierTitleDrugs
NCT01171963Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants
NCT00420745To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants
NCT00443846RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)
NCT03207750This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine
NCT00474526A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants